Search clinical trials for: 10 mg Obeticholic Acid (OCA)
Total 2968 results
-
Naga P. ChalasaniNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Intercept PharmaceuticalsTerminatedAlcoholic HepatitisUnited States
-
Intercept PharmaceuticalsCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Spain, France, Australia, New Zealand, Puerto Rico, Germany, Canada, United Kingdom, Hungary, Poland, Ukraine
-
Suthat LiangpunsakulNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Intercept PharmaceuticalsCompletedAlcohol ConsumptionUnited States
-
Intercept PharmaceuticalsSyneos Health; Global PBC Study Group; Target RWE; UK PBC Study GroupWithdrawnPrimary Biliary CholangitisUnited States
-
Intercept PharmaceuticalsSyneos Health; Global PBC Study Group; Target RWE; UK PBC GroupCompletedPrimary Biliary CholangitisUnited States
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingPrimary Biliary CholangitisChina
-
National Institute of Diabetes and Digestive and...CompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States
-
Intercept PharmaceuticalsCompletedPrimary Sclerosing Cholangitis (PSC)United States, Italy
-
Intercept PharmaceuticalsCompleted
-
Intercept PharmaceuticalsCompletedHealthyUnited States
-
Intercept PharmaceuticalsTerminatedBiliary AtresiaIsrael, United Kingdom, Poland, Belgium, France, Germany, Italy, Netherlands, Spain
-
Intercept PharmaceuticalsTerminatedLiver Cirrhosis, BiliaryUnited States, Spain, Korea, Republic of, Australia, Finland, Israel, Lithuania, United Kingdom, Belgium, Netherlands, Estonia, Brazil, Italy, Serbia, Sweden, Argentina, Austria, Canada, Chile, Denmark, France, Germany, Hong Kong, Hun... and more
-
Intercept PharmaceuticalsTerminatedLiver Cirrhosis, BiliaryUnited States, Argentina, Spain, Belgium, Germany, Canada, Australia, Estonia, Brazil, Hungary, Italy, Lithuania
-
Intercept PharmaceuticalsActive, not recruitingPrimary Biliary CholangitisNetherlands, United Kingdom, Korea, Republic of, Germany, Australia, Estonia, Belgium, France, Czechia, Croatia, Greece, Hungary, Israel, Lithuania, Norway, Poland, Spain
-
Intercept PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Intercept PharmaceuticalsActive, not recruitingPrimary Biliary CholangitisUnited States
-
Intercept PharmaceuticalsCompletedLiver Cirrhosis, BiliaryUnited States, France, Germany, Spain, United Kingdom, Canada, Austria
-
GlaxoSmithKlineCompletedPruritusUnited States
-
Intercept PharmaceuticalsCompletedPrimary Biliary CirrhosisUnited States, Spain, United Kingdom, Austria, Netherlands, Australia, Italy, Germany, Poland, Sweden, France, Canada, Belgium
-
Sahlgrenska University Hospital, SwedenUnknown
-
GlaxoSmithKlineCompletedCholestasisUnited Kingdom
-
Abhimanyu GargCompletedFamilial Partial LipodystrophyUnited States
-
Tanta UniversityActive, not recruitingNon-alcoholic SteatohepatitisEgypt
-
Intercept PharmaceuticalsTerminatedLiver Cirrhosis, BiliaryUnited States, Spain, Canada, United Kingdom, France, Germany, Austria, Netherlands
-
Intercept PharmaceuticalsCompletedNonalcoholic SteatohepatitisUnited States
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingPrimary Biliary CirrhosisChina
-
Universitaire Ziekenhuizen KU LeuvenIntercept PharmaceuticalsRecruiting
-
University of AarhusCompletedEffect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CTPrimary Biliary CirrhosisDenmark
-
Sir Salimullah Medical College Mitford HospitalCompletedNon-Alcoholic Fatty Liver DiseaseBangladesh
-
Imperial College Healthcare NHS TrustCompletedPrimary Bile Acid Malabsorption | Secondary Bile Acid Malabsorption | Chronic DiarrhoeaUnited Kingdom
-
Seoul National University HospitalGangnam Severance HospitalRecruitingDiabetes Mellitus, Type 2 | Endocrine System Diseases | Dyslipidemias | Nutritional and Metabolic DiseasesKorea, Republic of
-
Organon and CoMerck Shering-Plough JV StudyCompleted
-
Organon and CoCompleted
-
Ache Laboratorios Farmaceuticos S.A.CompletedDyslipidemia | HypercholesterolemiaBrazil
-
Organon and CoCompleted
-
University of LeipzigHannover Medical School; RWTH Aachen University; Academisch Medisch Centrum -... and other collaboratorsRecruitingPrimary Biliary Cholangitis | PBCGermany
-
Sahlgrenska University Hospital, SwedenMedical University of ViennaCompleted
-
Samsung Medical CenterHanmi Pharmaceutical co., ltd.Active, not recruitingCoronary Artery DiseaseKorea, Republic of
-
Intercept PharmaceuticalsCompletedPrimary Biliary CirrhosisUnited States
-
PfizerCompleted
-
Esperion Therapeutics, Inc.Recruiting
-
Organon and CoCompleted
-
Idorsia Pharmaceuticals Ltd.Completed
-
Vedic Lifesciences Pvt. Ltd.Not yet recruitingUpper Respiratory Tract InfectionsIndia
-
Ferring PharmaceuticalsCompletedChronic Idiopathic ConstipationUnited States, Belgium, Canada, Czech Republic, Hungary, Poland, Slovakia, South Africa, Sweden, United Kingdom
-
Organon and CoCompletedHypercholesterolemia | Heterozygous Familial Hypercholesterolemia
-
Ambrilia Biopharma, Inc.TerminatedAcromegalyUnited States, Belarus, Hungary, Serbia, Ukraine, Romania
-
Merck Sharp & Dohme LLCCompleted